KEAP1 and Cerebral ischemia: A study has shown that Britanin leading to the induction of the Nrf2 pathway ameliorated cerebral ischemia–reperfusion injury by selectively binding to cysteine 151 of Keap1 and inhibiting Keap1-mediated ubiquitylation of Nrf2 (Wu et al., 2017).